By the clinical team at Next Step Psychiatry • Lilburn, GA
A Game-Changer for Postpartum Depression
For decades, new mothers with postpartum depression had limited options—SSRIs that take weeks to work, or brexanolone (Zulresso), an IV infusion requiring a 60-hour hospital stay costing $34,000. Then in August 2023, the FDA approved zuranolone (Zurzuvae), the first oral pill specifically designed for postpartum depression. It works within days, not weeks, and you take it at home for just 14 days.
This approval represents a seismic shift in how we treat postpartum depression. At Next Step Psychiatry, we believe every new mother deserves access to the most effective treatment available.
How Zuranolone Works
Unlike traditional antidepressants that target serotonin, zuranolone modulates GABA-A receptors—the same system targeted by your brain’s natural neurosteroid allopregnanolone. During pregnancy, allopregnanolone levels rise dramatically, then crash after delivery. This sudden drop is believed to trigger postpartum depression in susceptible women.
Zuranolone essentially replaces what your brain suddenly lost after delivery. That’s why it works so quickly—it’s addressing the root hormonal cause rather than broadly increasing serotonin levels.
Clinical Trial Results
In the SKYLARK clinical trial, women taking zuranolone showed significant improvement in depressive symptoms as early as day 3. By day 15 (the day after completing the 14-day course), the improvement was substantial and statistically significant. Many women maintained these benefits for weeks after stopping the medication, though some required additional treatment.
Side effects were generally mild: drowsiness, dizziness, and sedation were the most common. Zuranolone is taken at night with a fatty snack (which improves absorption), and most women slept through the sedative effects.
| Feature | Zuranolone (Zurzuvae) | SSRIs (e.g., Zoloft) | Brexanolone (Zulresso) |
|---|---|---|---|
| How taken | Pill (at home) | Daily pill | 60-hour IV infusion |
| Onset of action | 3–5 days | 4–6 weeks | 24–48 hours |
| Treatment duration | 14 days | 6–12+ months | 60 hours (one-time) |
| Setting | Home | Home | Hospital only |
| Approximate cost | ~$15,900 (before insurance) | $10–30/month generic | ~$34,000 |
Who Is a Good Candidate?
Zuranolone is approved for adults with postpartum depression, typically defined as a major depressive episode occurring during the third trimester or within four weeks of delivery (though clinically, postpartum depression can begin anytime in the first year). Ideal candidates include women with moderate to severe symptoms who need rapid relief, especially those who are having difficulty bonding with their baby, functioning in daily life, or caring for their newborn.
- Women with moderate to severe postpartum depressive symptoms
- Those who need rapid relief and cannot wait 4–6 weeks for SSRIs
- Mothers who prefer a short, defined treatment course over indefinite daily medication
- Women who have not responded to or cannot tolerate traditional antidepressants
Getting Treatment in Georgia
At Next Step Psychiatry, we evaluate new and expecting mothers for postpartum depression and discuss all available treatment options, including zuranolone. We accept most major insurance plans and offer telepsychiatry appointments throughout Georgia—so you don’t have to leave your baby to get the help you need.
Related Articles
Ready to Take the Next Step?
Our board-certified psychiatrists are here to help. We accept most major insurance plans including Medicare, Medicaid, Aetna, Cigna, Blue Cross Blue Shield, and United Healthcare.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. If you or someone you know is in crisis, call 911 or the 988 Suicide & Crisis Lifeline.